Journal Article Epublish 132 citations
PubMed: 39055398 DOI: 10.1016/j.csbj.2024.06.035
Mime: A flexible machine-learning framework to construct and visualize models for clinical characteristics prediction and feature selection.
Comput Struct Biotechnol J 23:2798-2810
Authors: Hongwei Liu, Wei Zhang, Yihao Zhang, Abraham Ayodeji Adegboro, Deborah Oluwatosin Fasoranti, Luohuan Dai, Zhouyang Pan, Hongyi Liu, Yi Xiong, Wang Li, Kang Peng, Siyi Wanggou, Xuejun Li
Affiliations
- Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
- Hunan International Scientific and Technological Cooperation Base of Brain Tumor Research, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
- Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China. Hunan International Scientific and Technological Cooperation Base of Brain Tumor Research, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
- Hunan International Scientific and Technological Cooperation Base of Brain Tumor Research, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China. Department of Radiology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
Abstract
The widespread use of high-throughput sequencing technologies has revolutionized the understanding of biology and cancer heterogeneity. Recently, several machine-learning models based on transcriptional data have been developed to accurately predict patients' outcome and clinical response. However, an open-source R package covering state-of-the-art machine-learning algorithms for user-friendly access has yet to be developed. Thus, we proposed a flexible computational framework to construct a machine learning-based integration model with elegant performance (Mime). Mime streamlines the process of developing predictive models with high accuracy, leveraging complex datasets to identify critical genes associated with prognosis. An in silico combined model based on de novo PIEZO1-associated signatures constructed by Mime demonstrated high accuracy in predicting the outcomes of patients compared with other published models. Furthermore, the PIEZO1-associated signatures could also precisely infer immunotherapy response by applying different algorithms in Mime. Finally, SDC1 selected from the PIEZO1-associated signatures demonstrated high potential as a glioma target. Taken together, our package provides a user-friendly solution for constructing machine learning-based integration models and will be greatly expanded to provide valuable insights into current fields. The Mime package is available on GitHub (https://github.com/l-magnificence/Mime).
MeSH
Algorithms, Machine Learning, Learning
Cited by
- Multi-omics analysis constructs a novel neuroendocrine prostate cancer classifier and classification system. Sci Rep, 2025
- Large-scale bulk and single-cell RNA sequencing combined with machine learning reveals glioblastoma-associated neutrophil heterogeneity and establishes a VEGFA + neutrophil prognostic model. Biol Direct, 2025
- Machine learning analysis identified NNMT as a potential therapeutic target for hepatocellular carcinoma based on PCD-related genes. Sci Rep, 2025
- Impact of glioma metabolism-related gene ALPK1 on tumor immune heterogeneity and the regulation of the TGF-β pathway. Front Immunol, 2025
- Comprehensive Analysis of Multi-Omics Data on RNA Polymerase as an Adverse Factor in Head and Neck Squamous Cell Carcinoma. J Inflamm Res, 2025
- Development of a MVI associated HCC prognostic model through single cell transcriptomic analysis and 101 machine learning algorithms. Sci Rep, 2025
- Integrative network pharmacology and multi-omics reveal anisodamine hydrobromide's multi-target mechanisms in sepsis. Sci Rep, 2025
- Integrative multi-omics and machine learning reveal critical functions of proliferating cells in prognosis and personalized treatment of lung adenocarcinoma. NPJ Precis Oncol, 2025
- Establishment of a prognostic model based on ER stress-related cell death genes and proposing a novel combination therapy in acute myeloid leukemia. J Transl Med, 2025
- Integration of Multi-Scale Profiling and Machine Learning Reveals the Prognostic Role of Extracellular Matrix-Related Cancer-Associated Fibroblasts in Lung Adenocarcinoma. Int J Med Sci, 2025
- Transcriptome analysis reveals the potential role of neural factor EN1 for long-terms survival in estrogen receptor-independent breast cancer. Mol Ther Oncol, 2025
- Transcriptome-wide analysis reveals potential roles of CFD and ANGPTL4 in fibroblasts regulating B cell lineage for extracellular matrix-driven clustering and novel avenues for immunotherapy in breast cancer. Mol Med, 2025
- GMIP: A Novel Prognostic Biomarker Influencing Immune Infiltration and Tumour Dynamics Across Cancer Types. J Cell Mol Med, 2025
- Evaluation of pyroptosis-associated genes in endometrial cancer utilizing a 101-combination machine learning framework and multi-omics data. Front Med (Lausanne), 2025
- Innate immune cell barrier-related genes inform precision prognosis in pancreatic cancer. Front Immunol, 2025
- Multi-Omics Integration: Predicting Progression and Optimizing Clinical Treatment of Hepatocellular Carcinoma Through Malignant-Cell-Related Genes. Int J Mol Sci, 2025
- Seminal plasma PGK2 serves as a predictive biomarker for post-varicocelectomy sperm motility improvement in varicocele subjects. Transl Androl Urol, 2025
- Random survival forest algorithm for risk stratification and survival prediction in gastric neuroendocrine neoplasms. Sci Rep, 2024
- Machine learning-driven SLC prognostic signature for glioma: predicting survival and immunotherapy response. Front Pharmacol, 2025
- Epithelial-mesenchymal transition classification based on machine learning for predicting prognosis and treatment response in clear cell renal cell carcinoma. Transl Androl Urol, 2025